Home LiteratureArticle Details
PMID: 12426129 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review

The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.

Environmental health perspectives ·Vol. 110 Suppl 5 ·2002-10-00 ·Pages 767-71

Stýblo M, Drobná Z, Jaspers I, Lin S, Thomas DJ

Abstract

Recent research of the metabolism and biological effects of arsenic has profoundly changed our understanding of the role of metabolism in modulation of toxicity and carcinogenicity of this metalloid. Historically, the enzymatic conversion of inorganic arsenic to mono- and dimethylated species has been considered a major mechanism for detoxification of inorganic arsenic. However, compelling experimental evidence obtained from several laboratories suggests that biomethylation, particularly the production of methylated metabolites that contain trivalent arsenic, is a process that activates arsenic as a toxin and a carcinogen. This article summarizes this evidence and provides new data on a) the toxicity of methylated trivalent arsenicals in mammalian cells, b) the effects of methylated trivalent arsenicals on gene transcription, and c) the mechanisms involved in arsenic methylation in animal and human tissues.

MeSH Terms
Animals Arsenic/metabolism,toxicity Biotransformation Cell Line Cell Transformation, Neoplastic Humans Mammals Methylation Methyltransferases/pharmacology Transcription, Genetic/drug effects
Chemicals
Methyltransferases Arsenic
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Stýblo Miroslav
Department of Pediatrics, Center for Environmental Medicine and Lung Biology, Burnett-Womack Clinical Sciences Building, University of North Carolina, Chapel Hill, NC 27599-7220, USA. [email protected]
Drobná Zuzana
Jaspers Ilona
Lin Shan
Thomas David J
References (34)
34 references, click to expand
  1. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    J Environ Pathol Toxicol Oncol. 2000;19(3):281-6 PMID: 10983894
  2. Induction of p53 protein expression by sodium arsenite.
    Mutat Res. 1997 Nov 28;381(2):259-65 PMID: 9434882
  3. Speciation of key arsenic metabolic intermediates in human urine.
    Anal Chem. 2000 Nov 1;72(21):5172-7 PMID: 11080860
  4. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.
    Environ Health Perspect. 2000 Nov;108(11):1015-8 PMID: 11102289
  5. Methylated trivalent arsenic species are genotoxic.
    Chem Res Toxicol. 2001 Apr;14(4):355-61 PMID: 11304123
  6. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India.
    Chem Res Toxicol. 2001 Apr;14(4):371-8 PMID: 11304125
  7. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
    Toxicol Appl Pharmacol. 2001 May 1;172(3):225-32 PMID: 11312651
  8. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Toxicol Appl Pharmacol. 2001 May 1;172(3):249-61 PMID: 11312654
  9. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase.
    Chem Res Toxicol. 2001 Jun;14(6):651-6 PMID: 11409934
  10. Determination of trivalent methylated arsenicals in biological matrices.
    Toxicol Appl Pharmacol. 2001 Aug 1;174(3):282-93 PMID: 11485389
  11. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily.
    Chem Res Toxicol. 2001 Aug;14(8):1051-7 PMID: 11511179
  12. The cellular metabolism and systemic toxicity of arsenic.
    Toxicol Appl Pharmacol. 2001 Oct 15;176(2):127-44 PMID: 11601889
  13. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol.
    J Biol Chem. 2002 Mar 29;277(13):10795-803 PMID: 11790780
  14. Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase.
    Chem Res Toxicol. 1999 Dec;12(12):1278-83 PMID: 10604879
  15. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase.
    Chem Res Toxicol. 2000 Jan;13(1):26-30 PMID: 10649963
  16. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes.
    Toxicol Appl Pharmacol. 2000 Mar 1;163(2):203-7 PMID: 10698679
  17. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation.
    Cancer Res. 2000 Jul 1;60(13):3445-53 PMID: 10910055
  18. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic.
    Chem Res Toxicol. 2000 Aug;13(8):693-7 PMID: 10956055
  19. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man.
    Arch Toxicol. 1985 Jun;57(2):125-9 PMID: 4026571
  20. Thioredoxin and glutaredoxin systems.
    J Biol Chem. 1989 Aug 25;264(24):13963-6 PMID: 2668278
  21. Arsenic ingestion and internal cancers: a review.
    Am J Epidemiol. 1992 Mar 1;135(5):462-76 PMID: 1570813
  22. Reactions of arsenic(III) and arsenic(V) species with glutathione.
    Chem Res Toxicol. 1993 Jan-Feb;6(1):102-6 PMID: 8448339
  23. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study.
    Chem Biol Interact. 1994 Feb;90(2):139-55 PMID: 8156604
  24. Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide.
    Structure. 1995 Mar 15;3(3):239-43 PMID: 7788289
  25. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver.
    Chem Res Toxicol. 1995 Dec;8(8):1029-38 PMID: 8605285
  26. Mono- and dimethylation of arsenic in rat liver cytosol in vitro.
    Chem Biol Interact. 1996 Jan 5;99(1-3):147-64 PMID: 8620564
  27. Drinking water and cancer.
    Environ Health Perspect. 1995 Nov;103 Suppl 8:225-31 PMID: 8741788
  28. Dermatotoxic chemical stimulate of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes.
    Res Commun Mol Pathol Pharmacol. 1996 Aug;93(2):131-48 PMID: 8884985
  29. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells.
    Free Radic Biol Med. 1996;21(6):783-90 PMID: 8902524
  30. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.
    EMBO J. 1996 Nov 15;15(22):6269-79 PMID: 8947050
  31. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols.
    Chem Res Toxicol. 1997 Jan;10(1):27-33 PMID: 9074799
  32. Arsenic in drinking water and incidence of urinary cancers.
    Epidemiology. 1997 Sep;8(5):545-50 PMID: 9270957
  33. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase.
    Chem Res Toxicol. 1999 Oct;12(10):924-30 PMID: 10525267
  34. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells.
    Arch Toxicol. 2000 Aug;74(6):289-99 PMID: 11005674
Article Info
Journal
Environmental health perspectives
Abbr.
Environ Health Perspect
ISSN
0091-6765
Published
2002-10-00
Pages
767-71
Language
English
Region
United States
NLM ID
0330411
PMCID
PMC1241242
Subset
IM
Grants
NIDDK NIH HHS · DK 56350 · United States
NIEHS NIH HHS · ES 09941 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]